More Australian Clinical Labs Ltd news
Australian Clinical Labs LtdASX: ACL

Sale of Crescent Capital shareholding

Sep 11, 2024 at 11:35 PM EDT · Issued by Australian Clinical Labs Ltd

Filed with ASX · Sep 11, 2024 at 11:35 PM EDT · 1 page · English

On 6ix: 6ix.com/news/sale-of-crescent-capital-shareholding

Australian Clinical Labs Ltd on 6ix

Story so far

  • Second letter from Crescent CapitalAug 12, 2022
  • Letter received from Crescent CapitalAug 12, 2022
  • Letter from Crescent Capital PartnersDec 21, 2021

Earlier from Australian Clinical Labs

  • Notification of buy-back - ACLAug 28, 2024
  • FY24 financial results investor presentationAug 28, 2024
  • Appendix 4E and FY24 financial statementsAug 28, 2024
  • FY24 Trading UpdateMay 21, 2024
  • Appendix 4D and 1H24 financial reportsFeb 27, 2024

Later from Australian Clinical Labs

  • 1H25 financial results investor presentationFeb 25, 2025
  • Appendix 4D and 1H25 financial statementsFeb 25, 2025
  • Response to ASX Aware LetterFeb 27, 2025
  • FY25 Results PresentationAug 25, 2025
  • FY25 Results AnnouncementAug 25, 2025
All Australian Clinical Labs news releases↗

Follow Australian Clinical Labs into a list and get an email when it puts out news.

Follow Australian Clinical Labs
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer